Diagnostic Potential of MicroRNA-1, MicroRNA-21, and MicroRNA-29 as Novel Biomarkers for Early Development of Myocardial Fibrosis in Heart Failure with Preserved Ejection Fraction
How to cite: Andrianto, A.; Al-Farabi, M. J.; Arifitrianto, M. G.; Juwita, R. R.; Firmansyah, O. W.; Intan, R. E.; Fadila, A. N.; Tiyantara, M. S.; Suryawan, I. G. R.; Ardiana, M.; Rahmianti, N. D.; Pikir, B. S.; Nugraha, R. A. Diagnostic Potential of MicroRNA-1, MicroRNA-21, and MicroRNA-29 as Novel Biomarkers for Early Development of Myocardial Fibrosis in Heart Failure with Preserved Ejection Fraction. Preprints 2023, 2023081284. https://doi.org/10.20944/preprints202308.1284.v1 Andrianto, A.; Al-Farabi, M. J.; Arifitrianto, M. G.; Juwita, R. R.; Firmansyah, O. W.; Intan, R. E.; Fadila, A. N.; Tiyantara, M. S.; Suryawan, I. G. R.; Ardiana, M.; Rahmianti, N. D.; Pikir, B. S.; Nugraha, R. A. Diagnostic Potential of MicroRNA-1, MicroRNA-21, and MicroRNA-29 as Novel Biomarkers for Early Development of Myocardial Fibrosis in Heart Failure with Preserved Ejection Fraction. Preprints 2023, 2023081284. https://doi.org/10.20944/preprints202308.1284.v1
Abstract
Keywords
Subject
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)